Introduction
Pharmaceutical chemists have to carry out extremely routine tasks, such as optimizing reaction conditions and synthesizing many derivatives on the several hundred milligram scale for determining biological activity at the early stage of screening. To release chemists from these time-consuming tasks, the authors have been developing automated synthesis systems equipped with an artificial intelligence (see table 1 ). With the first system, over 200 derivatives of substituted N-(carboxyalkyl)amino acids [1] [2] [3] [4] were synthesized. The design of this first-generation system was based on a one-way operating system from the mixing of reactants to the isolation of products. This paper reports on improved second and third generation systems. They consist of modular units, which can be operated together or independently (see figure 1) , and are controlled with user-friendly software. shown in figure 2 and A/M auto/manual changeover switch; SWP switch panel. Details of the synthesis projects performed with these systems will be published in future papers.
